{"id":"systemic-therapy-standard-of-care","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Pneumonitis"},{"rate":"5-10%","effect":"Hypothyroidism"},{"rate":"10-20%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL261657","moleculeType":"Small molecule","molecularWeight":"405.37"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to PD-1, the drug prevents cancer cells from evading the immune system, allowing the body's immune cells to attack and destroy the cancer cells. This leads to an anti-tumor response and potentially prolonged survival in patients with certain types of cancer.","oneSentence":"This drug targets the PD-1 receptor to inhibit cancer cell growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:06.495Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer, PD-L1 positive"},{"name":"Metastatic melanoma"},{"name":"Head and neck squamous cell carcinoma"}]},"trialDetails":[{"nctId":"NCT07495657","phase":"","title":"Pre-Post Multimodal Assessment Of Severe Psoriasis Vulgaris Using Clinical, Dermoscopic And QoL Measures","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05-01","conditions":"Psoriasis Vulgaris","enrollment":45},{"nctId":"NCT03784755","phase":"NA","title":"Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2019-11-15","conditions":"Prostate Cancer Metastatic","enrollment":409},{"nctId":"NCT07424547","phase":"PHASE1","title":"Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Conjupro Biotherapeutics, Inc.","startDate":"2026-03-03","conditions":"Cancer, Solid Tumor Cancer, Advanced Metastatic Cancer","enrollment":386},{"nctId":"NCT03387553","phase":"EARLY_PHASE1","title":"HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-06-06","conditions":"Breast Cancer, Breast Cancer Female, Breast Cancer, Male","enrollment":31},{"nctId":"NCT06686771","phase":"PHASE3","title":"Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2025-12-16","conditions":"Non-small Cell Lung Cancer","enrollment":320},{"nctId":"NCT04929041","phase":"PHASE2, PHASE3","title":"Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2022-10-07","conditions":"Lung Adenocarcinoma, Lung Adenosquamous Carcinoma, Lung Non-Small Cell Carcinoma","enrollment":427},{"nctId":"NCT05024214","phase":"PHASE1, PHASE2","title":"Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors","status":"RECRUITING","sponsor":"3D Medicines (Sichuan) Co., Ltd.","startDate":"2021-11-15","conditions":"Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma","enrollment":170},{"nctId":"NCT04998682","phase":"NA","title":"Prospective Evaluation of Targeted Axillary Dissection (TAD)","status":"COMPLETED","sponsor":"University of Miami","startDate":"2022-03-01","conditions":"Breast Cancer","enrollment":20},{"nctId":"NCT07311512","phase":"NA","title":"PMPR and Chlorhexidine on Periodontal Disease and Vascular Function","status":"RECRUITING","sponsor":"Mahdi Mutahar","startDate":"2026-01-23","conditions":"Periodontal Disease (PD), Cardio Vascular Disease, Oral-Systemic Link","enrollment":30},{"nctId":"NCT05863195","phase":"PHASE3","title":"Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2023-10-19","conditions":"Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8","enrollment":408},{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT02654119","phase":"PHASE2","title":"Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2015-12-11","conditions":"HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7","enrollment":20},{"nctId":"NCT07001748","phase":"PHASE2, PHASE3","title":"Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2025-08-19","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis","enrollment":148},{"nctId":"NCT07227597","phase":"PHASE1, PHASE2","title":"A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-29","conditions":"Small Cell Lung Cancer Extensive Stage","enrollment":170},{"nctId":"NCT07484932","phase":"NA","title":"TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-05-01","conditions":"Cancer (Solid Tumors), Geriatric Oncology","enrollment":400},{"nctId":"NCT05352919","phase":"PHASE3","title":"An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus","status":"ENROLLING_BY_INVITATION","sponsor":"Biogen","startDate":"2022-06-10","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":864},{"nctId":"NCT01729455","phase":"","title":"Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-02-21","conditions":"Systemic Lupus Erythematosus","enrollment":3138},{"nctId":"NCT07355218","phase":"PHASE3","title":"A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)","status":"NOT_YET_RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2026-03-27","conditions":"Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus","enrollment":202},{"nctId":"NCT05268289","phase":"PHASE2","title":"Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-10","conditions":"Lupus Nephritis","enrollment":240},{"nctId":"NCT07485296","phase":"PHASE2","title":"Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC)","status":"RECRUITING","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2026-01-27","conditions":"Head & Neck Squamous Cell Carcinoma","enrollment":45},{"nctId":"NCT07332481","phase":"PHASE3","title":"A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease","status":"NOT_YET_RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2026-03-27","conditions":"Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)","enrollment":202},{"nctId":"NCT07481799","phase":"PHASE3","title":"Efficacy and Safety of SBRT Combined With Becotatug Vedotin in EGFR-Positive Metastatic Tumor Patients With Oligometastases","status":"NOT_YET_RECRUITING","sponsor":"Ming-Yuan Chen","startDate":"2026-03-01","conditions":"Oligo-metastatic Cancer","enrollment":200},{"nctId":"NCT06795893","phase":"","title":"The Anifrolumab PRIM Program","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-07","conditions":"Systemic Lupus Erythematosus","enrollment":240},{"nctId":"NCT05126277","phase":"PHASE3","title":"Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-07-14","conditions":"Lupus Nephritis","enrollment":462},{"nctId":"NCT03684980","phase":"EARLY_PHASE1","title":"LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-11-14","conditions":"Central Nervous System Lymphoma","enrollment":58},{"nctId":"NCT06211257","phase":"NA","title":"Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.","status":"RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2024-05-29","conditions":"Sarcoma Metastatic, Locally Advanced Soft Tissue Sarcoma","enrollment":377},{"nctId":"NCT07481097","phase":"NA","title":"Hemodynamic Resuscitation Guided by Non-Invasive Mean Systemic Filling Pressure to Prevent Acute Kidney Injury in Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04-01","conditions":"Acute Kidney Injury Due to Sepsis","enrollment":100},{"nctId":"NCT06973161","phase":"","title":"ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-10","conditions":"Bladder Cancer, Biliary Tract Cancer, Cervical Cancer","enrollment":105},{"nctId":"NCT07477418","phase":"PHASE1, PHASE2","title":"PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)","status":"NOT_YET_RECRUITING","sponsor":"University of Vermont","startDate":"2026-12","conditions":"Pancreatic Ductal Adenocarcinoma (PDAC), Borderline Resectable Pancreatic Cancer, Pancreatic Neoplasms","enrollment":10},{"nctId":"NCT06969833","phase":"NA","title":"Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma","status":"RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2025-06-27","conditions":"Cancer of the Ovary, Cancer of the Fallopian Tube, Peritoneal Cancer","enrollment":371},{"nctId":"NCT07478471","phase":"","title":"Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax","status":"NOT_YET_RECRUITING","sponsor":"Emergent BioSolutions","startDate":"2027-05","conditions":"Infections, Bacterial","enrollment":10},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT06659029","phase":"","title":"Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-07-01","conditions":"Systemic Lupus Erythematosus","enrollment":442},{"nctId":"NCT04042935","phase":"PHASE1","title":"Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-02-27","conditions":"HNSCC","enrollment":5},{"nctId":"NCT07175285","phase":"","title":"A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-10-08","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":223},{"nctId":"NCT06561048","phase":"PHASE3","title":"Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma","status":"RECRUITING","sponsor":"Corvus Pharmaceuticals, Inc.","startDate":"2024-10-02","conditions":"Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma","enrollment":150},{"nctId":"NCT07290803","phase":"","title":"This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-11-17","conditions":"Atopic Dermatitis","enrollment":1000},{"nctId":"NCT06741969","phase":"PHASE3","title":"Nipocalimab in Moderate to Severe Sjogren's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-12-04","conditions":"Sjogrens Syndrome","enrollment":655},{"nctId":"NCT07438496","phase":"PHASE3","title":"A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2026-03-05","conditions":"Lupus Erythematosus, Systemic","enrollment":600},{"nctId":"NCT07469072","phase":"PHASE2","title":"Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2026-02-25","conditions":"Continuous Renal Replacement Therapy (CRRT)","enrollment":92},{"nctId":"NCT00508547","phase":"","title":"Psoriasis Longitudinal Assessment and Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Scientific Affairs, LLC","startDate":"2007-06-21","conditions":"Psoriasis","enrollment":15842},{"nctId":"NCT06858735","phase":"PHASE2","title":"HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-06-10","conditions":"Advanced Intrahepatic Cholangiocarcinoma","enrollment":60},{"nctId":"NCT05636176","phase":"PHASE3","title":"A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2023-05-08","conditions":"Heart Failure","enrollment":5600},{"nctId":"NCT06200207","phase":"PHASE3","title":"A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2024-04-01","conditions":"Heart Failure, Systemic Inflammation","enrollment":680},{"nctId":"NCT07461961","phase":"PHASE2","title":"CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-07-01","conditions":"Cardiogenic Shock, Heart Failure, Inflammation","enrollment":30},{"nctId":"NCT07463040","phase":"PHASE3","title":"Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)","status":"NOT_YET_RECRUITING","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2027-01-01","conditions":"Cutaneous Leihmaniasis","enrollment":900},{"nctId":"NCT04716699","phase":"PHASE1","title":"Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2021-01-20","conditions":"Glioblastoma","enrollment":12},{"nctId":"NCT05624749","phase":"PHASE3","title":"Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-04-21","conditions":"Systemic Lupus Erythematosus","enrollment":288},{"nctId":"NCT05660408","phase":"PHASE1, PHASE2","title":"RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2025-03-12","conditions":"Recurrent Pulmonary Osteosarcoma, Recurrent High-grade Glioma","enrollment":36},{"nctId":"NCT07459127","phase":"","title":"Multicenter Retrospective Cohort of Pulmonary NUT Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Three Gorges Hospital of Chongqing University","startDate":"2023-01-01","conditions":"NUT Carcinoma","enrollment":150},{"nctId":"NCT05639114","phase":"PHASE3","title":"Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-03-02","conditions":"Systemic Lupus Erythematosus","enrollment":436},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT07191418","phase":"NA","title":"Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors","status":"NOT_YET_RECRUITING","sponsor":"Roberto Valente","startDate":"2026-03","conditions":"Pancreatic Cancer Metastatic to Liver","enrollment":178},{"nctId":"NCT07291297","phase":"PHASE2","title":"Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-03-04","conditions":"Sarcoma Metastatic, Sarcoma, Soft Tissue","enrollment":50},{"nctId":"NCT05925218","phase":"","title":"Circulating Tumor DNA Collection From Patients With High Grade Gliomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2022-09-02","conditions":"High Grade Glioma","enrollment":70},{"nctId":"NCT07335562","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacaptagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","startDate":"2026-04-30","conditions":"Systemic Sclerosis","enrollment":92},{"nctId":"NCT04307914","phase":"NA","title":"Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"UMC Utrecht","startDate":"2020-03-10","conditions":"Bone Metastases, Bone Neoplasm, Bone Lesion","enrollment":216},{"nctId":"NCT06813664","phase":"PHASE2","title":"ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-04-01","conditions":"Metastatic NSCLC - Non-Small Cell Lung Cancer, OligoProgressive Metastatic Disease","enrollment":60},{"nctId":"NCT06063538","phase":"EARLY_PHASE1","title":"Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2024-02-15","conditions":"Atrial Fibrillation, Post-Op Complication","enrollment":63},{"nctId":"NCT05566795","phase":"PHASE3","title":"DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)","status":"RECRUITING","sponsor":"Day One Biopharmaceuticals, Inc.","startDate":"2023-02-27","conditions":"Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma","enrollment":400},{"nctId":"NCT05863351","phase":"PHASE3","title":"Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2023-09-07","conditions":"Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8","enrollment":472},{"nctId":"NCT07053085","phase":"PHASE2","title":"A Study of Surgery and Radiotherapy in People With Breast Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-09-17","conditions":"Metastatic Breast Cancer, HER2-positive Breast Cancer","enrollment":162},{"nctId":"NCT03808337","phase":"PHASE2","title":"Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2019-01-16","conditions":"Triple Negative Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer","enrollment":145},{"nctId":"NCT04343573","phase":"PHASE2","title":"Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-04-10","conditions":"Leptomeningeal Metastases","enrollment":102},{"nctId":"NCT04495309","phase":"NA","title":"Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2021-03-05","conditions":"Metastatic Breast Cancer","enrollment":87},{"nctId":"NCT07225036","phase":"NA","title":"Promoting Immunotherapy Efficacy With Low-Dose Liver RT","status":"RECRUITING","sponsor":"Jordan Kharofa","startDate":"2025-12-15","conditions":"Low-Dose Liver Radiation (LD-LRT), Non Small Cell Lung Cancer, Melanoma","enrollment":21},{"nctId":"NCT07439328","phase":"NA","title":"ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian Cancer","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2024-01-01","conditions":"Ovarian Cancer","enrollment":30},{"nctId":"NCT07431775","phase":"","title":"Saphnelo Use in Females of Child-bearing Potential","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-10-01","conditions":"Systemic Lupus Erythematosus","enrollment":26000000},{"nctId":"NCT05835310","phase":"PHASE3","title":"An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-03-14","conditions":"Systemic Lupus Erythematosus","enrollment":100},{"nctId":"NCT06283979","phase":"PHASE2","title":"A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.","status":"RECRUITING","sponsor":"Biocomposites Ltd","startDate":"2025-06-15","conditions":"Pressure Ulcer, Stage IV, Osteomyelitis","enrollment":60},{"nctId":"NCT01649765","phase":"PHASE2","title":"Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-09-07","conditions":"Systemic Lupus Erythematosus","enrollment":93},{"nctId":"NCT02786186","phase":"","title":"A Registry of Patients With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2015-12-23","conditions":"Psoriasis","enrollment":2376},{"nctId":"NCT05403723","phase":"PHASE1","title":"Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC","status":"SUSPENDED","sponsor":"University of Maryland, Baltimore","startDate":"2026-06-30","conditions":"Extensive-stage Small-cell Lung Cancer","enrollment":50},{"nctId":"NCT07404462","phase":"","title":"Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2017-03-01","conditions":"Breast Cancer, Early Breast Cancer","enrollment":171},{"nctId":"NCT06290687","phase":"PHASE2","title":"Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-02-18","conditions":"Malignant Neoplasm of Bladder, Muscle Invasive Bladder Carcinoma","enrollment":40},{"nctId":"NCT07413523","phase":"NA","title":"Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA","status":"NOT_YET_RECRUITING","sponsor":"Istituto Clinico Humanitas","startDate":"2026-02-16","conditions":"Bladder Cancer, Urothelial Carcinoma (UC), Oligometastasis","enrollment":44},{"nctId":"NCT07414706","phase":"PHASE3","title":"Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-03","conditions":"Intravenous Lidocaine, Laparoscopic Surgery, Post Operative Recovery","enrollment":182},{"nctId":"NCT05534321","phase":"PHASE1, PHASE2","title":"Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2022-08-29","conditions":"Spine Metastases","enrollment":74},{"nctId":"NCT07408947","phase":"","title":"Clinical Severity in Scorpion Envenomation: Home Remedies, Delay to Medical Care, and Antivenom Dosing Strategies in an Emergency Department","status":"COMPLETED","sponsor":"University of Guadalajara","startDate":"2025-08-07","conditions":"Scorpion Envenomation","enrollment":3145},{"nctId":"NCT06764095","phase":"PHASE4","title":"Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-01-08","conditions":"Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma","enrollment":75},{"nctId":"NCT07406646","phase":"NA","title":"Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1)","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2021-11-02","conditions":"Renal Cell Carcinoma, Advanced Kidney Cancer","enrollment":91},{"nctId":"NCT07407920","phase":"PHASE2","title":"Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-10-09","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2-Positive Breast Carcinoma","enrollment":120},{"nctId":"NCT05535166","phase":"PHASE2","title":"Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-12-20","conditions":"Medulloblastoma","enrollment":130},{"nctId":"NCT06459427","phase":"NA","title":"A Multicenter, RAndomIzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With AI-assisted Robotic guidanCe for Hemorrhagic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Yanbing Yu","startDate":"2026-04","conditions":"Brain Stem Hemorrhage, Robotic Surgical Procedures","enrollment":142},{"nctId":"NCT06135714","phase":"PHASE3","title":"Metastasis-directed Therapy for Oligometastases of Breast Cancer","status":"RECRUITING","sponsor":"Tokyo Medical and Dental University","startDate":"2023-11-08","conditions":"Breast Cancer, Oligometastasis, Metastatic Breast Cancer","enrollment":340},{"nctId":"NCT07326137","phase":"","title":"A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-12-26","conditions":"Advanced Biliary Tract Cancer(BTC), Advanced Pancreatic Cancers, Cancer-related Pain","enrollment":103},{"nctId":"NCT06366347","phase":"PHASE2","title":"ALPINE: Maintenance Letrozole/Abemaciclib","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-09-25","conditions":"Endometrial Cancer, Recurrent Endometrial Cancer, TP53","enrollment":32},{"nctId":"NCT04895241","phase":"PHASE3","title":"A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biogen","startDate":"2021-05-25","conditions":"Lupus Erythematosus, Systemic","enrollment":548},{"nctId":"NCT07233928","phase":"NA","title":"Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers","status":"RECRUITING","sponsor":"Institut Claudius Regaud","startDate":"2026-02-06","conditions":"Early Breast Cancer, Metastatic Breast Cancer","enrollment":1050},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT07250477","phase":"PHASE2","title":"Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2026-01-30","conditions":"Non-small Cell Lung Cancer Stage IIIC, Non-small Cell Lung Cancer Stage IV, Non Small Cell Lung Cancer","enrollment":56},{"nctId":"NCT02633163","phase":"PHASE2","title":"Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2018-11-18","conditions":"Systemic Lupus Erythematosus","enrollment":81},{"nctId":"NCT04700124","phase":"PHASE3","title":"Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-04-21","conditions":"Bladder Cancer","enrollment":808},{"nctId":"NCT07381296","phase":"","title":"Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-02","conditions":"Rheumatoid Arthritis Disease Flare","enrollment":200},{"nctId":"NCT07201519","phase":"PHASE2","title":"Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy","status":"RECRUITING","sponsor":"Michael J Cavnar, MD","startDate":"2026-01-23","conditions":"Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma","enrollment":80},{"nctId":"NCT06739655","phase":"NA","title":"Preoperative Radiation Therapy and Immediate Breast Reconstruction","status":"RECRUITING","sponsor":"Cancer Research Antwerp","startDate":"2025-02-20","conditions":"Breast Neoplasms, Breast Carcinoma, Breast Adenocarcinoma","enrollment":180},{"nctId":"NCT07383519","phase":"NA","title":"Application of Photon Therapy Instrument Combined With Ultrasonic Debridement in Senile Third and Fourth Stage Pressure Injuries","status":"COMPLETED","sponsor":"Dahua Hospital, Xuhui District, Shanghai","startDate":"2023-05-01","conditions":"Photon Therapy, Ultrasonic Debridement, Combination Therapy","enrollment":118},{"nctId":"NCT06935474","phase":"PHASE1, PHASE2","title":"C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease","status":"NOT_YET_RECRUITING","sponsor":"AbelZeta Inc.","startDate":"2026-07","conditions":"Lupus Nephritis (LN)","enrollment":24},{"nctId":"NCT07381556","phase":"PHASE4","title":"Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2025-11-01","conditions":"Alopecia Areata(AA), Alopecia Areata (AA), Alopecia Totalis/Universalis","enrollment":50},{"nctId":"NCT05429320","phase":"PHASE2","title":"A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-06-15","conditions":"Non-small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Nsclc","enrollment":37}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3671,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Systemic Therapy/Standard of Care","genericName":"Systemic Therapy/Standard of Care","companyName":"Memorial Sloan Kettering Cancer Center","companyId":"memorial-sloan-kettering-cancer-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug targets the PD-1 receptor to inhibit cancer cell growth. Used for Metastatic non-small cell lung cancer, PD-L1 positive, Metastatic melanoma, Head and neck squamous cell carcinoma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}